Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality – a cohort study

YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages

(2014) S. Letuve et al.   JOURNAL OF IMMUNOLOGY

Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease

(2014) Mia Moberg et al.   TheScientificWorldJOURNAL

Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma

(2013) R. Shao et al.   CARCINOGENESIS

Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis

(2013) Didia Bismara Cury et al.   CELLULAR IMMUNOLOGY

Predictive Value of Elevated Neutrophil to Lymphocyte Ratio in Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocardial Infarction

(2013) Mehmet Ergelen et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Calprotectin — A Marker of Mortality in COPD? Results from a Prospective Cohort Study

(2013) Dennis B. Holmgaard et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis

(2013) Bilge Bulbul Sen et al.   Cutaneous and Ocular Toxicology

Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease: A Retrospective Study

(2013) Ersin Günay et al.   INFLAMMATION

Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis

(2013) Mu-Xing Li et al.   INTERNATIONAL JOURNAL OF CANCER

Serum calprotectin as a biomarker for Crohn's disease

(2013) M.-A. Meuwis et al.   Journal of Crohns & Colitis

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease

(2013) Dennis B Holmgaard et al.   BMC Pulmonary Medicine

Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2

(2013) Chuan Hua He et al.   Cell Reports

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

(2012) Bartolome R. Celli et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

(2012) S. Cedrés et al.   Clinical & Translational Oncology

Predictive Value of Neutrophil to Lymphocyte Ratio in Clinical Outcomes of Non-ST Elevation Myocardial Infarction and Unstable Angina Pectoris

(2012) Mehmet Gul et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

YKL-40 Induces IL-8 Expression from Bronchial Epithelium via MAPK (JNK and ERK) and NF- B Pathways, Causing Bronchial Smooth Muscle Proliferation and Migration

(2012) H. Tang et al.   JOURNAL OF IMMUNOLOGY

Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

(2012) Alvar Agustí et al.   PLoS One

Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis

(2012) Maria Kazakova et al.   RHEUMATOLOGY INTERNATIONAL

The Progression of Chronic Obstructive Pulmonary Disease Is Heterogeneous

(2011) Ciro Casanova et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

(2011) Chun Geun Lee et al.   Annual Review of Physiology

Plasma YKL-40 levels in healthy subjects from the general population

(2011) Stig E. Bojesen et al.   CLINICA CHIMICA ACTA

The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure

(2011) Marina Harutyunyan et al.   IMMUNOBIOLOGY

YKL-40 Is Differentially Expressed in Human Embryonic Stem Cells and in Cell Progeny of the Three Germ Layers

(2011) Christian B. Brøchner et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer

(2011) M Kawada et al.   ONCOGENE

Chronic Obstructive Pulmonary Disease Biomarker(s) for Disease Activity Needed—Urgently

(2010) Jørgen Vestbo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Role of Breast Regression Protein–39 in the Pathogenesis of Cigarette Smoke–Induced Inflammation and Emphysema

(2010) Hiroshi Matsuura et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Sputum and serum calprotectin are useful biomarkers during CF exacerbation

(2010) R.D. Gray et al.   Journal of Cystic Fibrosis

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

(2010) Nicoline M. Korthagen et al.   RESPIRATORY MEDICINE

Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence

(2010) N. J. Sinden et al.   THORAX

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

(2009) Isabelle Ray-Coquard et al.   CANCER RESEARCH

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease

(2009) J. Kastrup et al.   EUROPEAN HEART JOURNAL

Plasma YKL-40: a potential new cancer biomarker?

(2009) Julia S Johansen et al.   Future Oncology

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis

(2009) Chun Geun Lee et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Plasma YKL-40 levels are elevated in patients with chronic heart failure

(2009) Camilla Noelle Rathcke et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD

(2008) Juan P. de Torres et al.   CHEST